Reports: Issues Arise in 21st Century Cures Act; Delay Possible | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Reports: Issues Arise in 21st Century Cures Act; Delay Possible

October 28, 2016
by Rajiv Leventhal
| Reprints

The 21st Century Cures Act could be in danger of not passing this year following a statement from a coalition of liberal groups calling into question the bill’s ability to address high drug prices.

While the drug prices portion of the legislation isn’t of high relevance to the health IT community, if the bill is delayed or sunk completely, the health technology industry would likely be extremely disappointed. Stakeholders have touted the health IT provisions of the bill, particularly regarding FDA’s oversight of the sector, as well as encouraging interoperability of electronic health records (EHRs) and patient access to health data, and discouraging information blocking.  

As reported in Healthcare Informatics’ policy outlook in September, there has been hope that the health IT provisions that became part of the 21st Century Cures Act in the House will make it to President Obama’s desk this fall. As part of that story, Robert Horne, Health IT Now Coalition’s executive director, said, “We encourage the House and Senate to finish their work and get it to the President’s desk. We think it would be a huge, huge mistake to let this opportunity pass.”

But, according to an Oct. 27 report from The Hill, a spokesperson for Democrats on the House Energy and Commerce Committee said, the bill “’must include’ policies to address high drug prices, raising questions about whether Republicans would agree to such additions and help pass the bill this year.” The committee of Democrats released the statement after 13 liberal groups, including the Center for American Progress and the AFL-CIO, sent a letter to both chambers Wednesday calling for the bill to be punted to next year, so it can also deal with the hot-button topic of drug prices, The Hill reported.

Moving forward with this legislation now would be a missed opportunity to address unaffordable prescription drug prices,” the letter stated. “There is no justification for moving forward with legislation that provides substantial benefits to the drug industry without asking for something in return.”  The Hill report continued, “Still, the bill has backing from Republican leadership and is getting a strong push from its main sponsor, Energy and Commerce Chairman Fred Upton (R-Mich.).”

Meanwhile, a letter this week from the Charlotte, N.C.-based Premier, Inc., urged Congressional leadership to support the health IT provisions of the legislation.  Their statement read, “Premier is a strong supporter of HIT interoperability provisions that will improve the ability of healthcare providers, patients and researchers too seamlessly and securely access health information across different electronic health record (EHR) systems. In particular, we support having criteria that HIT would have to meet to be considered ‘interoperable’ and standards that set forth the categories for EHR vendors. Certification of EHRs should focus on the overall ability of EHR systems to retrieve and send data for patient care. This includes entity data-sharing programs that do not require vendor-specific interfaces and which are also tested in the real world. We have shared our detailed views with the committees of jurisdiction on HIT and ask that these and other important provisions be included in any final legislation.”

Premier’s statement continued, “Legislation to require greater HIT interoperability is essential to addressing these impediments to better connectivity between providers, smoother care transitions for patients and safer, more efficient delivery of care. For example, the legislation will help facilitate access to data in EHRs that can go into registries, an issue of great concern to physician groups in particular. Patients deserve the highest quality of care from all providers, which only can be achieved when we are able to communicate and coordinate care together.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.